newest glp-1 drugs Retatrutide for weight loss: Study shows 30% body weight loss What to Make of the
Description
Follow-up ranged from 12 months to 9 years

Diabetes Care (2019) 42(9):173341

Diabetes 64 , 25372549 (2015)

Early reports suggest appetite suppression onset is similar to tirzepatide, with meaningful effects within the first two to four weeks